Mysore S. Veena

2.4k citations

28 papers · 1.9k indexed · 2 hit papers · h-index 19

Molecular Medicine top 0.5%
- Curcumin's Biomedical Applications 6
Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism 5
- NF-κB Signaling Pathways 5
- MicroRNA in disease regulation 3
Pharmaceutical Science top 5%
Molecular Biology top 10%
- Retinoids in leukemia and cellular processes 6
- RNA Interference and Gene Delivery 3
- RNA modifications and cancer 3
Biomaterials top 10%
Oncology
- Cancer Cells and Metastasis 3

Co-authors: Eri S. Srivatsan Marilene B. Wang Reason Wilken Alen N. Cohen Saroj K. Basak Rita Chakrabarti Kym F. Faull Jeffrey D. Suh
Cited by: Molecular Medicine Cancer Research Pharmaceutical Science
Partner nations: United States Sweden India

In The Last Decade

Mysore S. Veena

27 papers receiving 1.8k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2025 Advances in CAR T cell therapy: antigen selection, modifications, and current trials for solid tumors
2011 Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma

Peers

Countries citing papers authored by Mysore S. Veena

Since Specialization

Citations

This map shows the geographic impact of Mysore S. Veena's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mysore S. Veena with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mysore S. Veena more than expected).

Fields of papers citing papers by Mysore S. Veena

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mysore S. Veena. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mysore S. Veena. The network helps show where Mysore S. Veena may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mysore S. Veena, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mysore S. Veena Line = papers co-authored together Mysore S. Veena links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Advances in CAR T cell therapy: antigen selection, modifications, and current trials for solid tumorsbreakdown → Salma Khan,Yeonjoo Choi,Mysore S. Veena,John K. Lee,Daniel Sanghoon Shin	2025	20
2	Enhanced CTLA‐4 blockade anti‐tumor immunity with APG‐157 combination in a murine head and neck cancer Daniel Sanghoon Shin,Saroj K. Basak,Mysore S. Veena,Begoña Comı́n-Anduix,Arjun Bhattacharya,Tien S. Dong,Albert Y. Ko,P. Han,Jonathan P. Jacobs,Neda A. Moatamed,Luis Miguel Sosa Ávila,Matteo Pellegrini,Marilene Wang,Eri S. Srivatsan	2024	1
3	DRUG REVIEW OF YAVANI (TRACHYSPERMUM AMMI) Gayatri Puttappa Katagi,Mysore S. Veena	2024	0
4	Acidification of intracellular pH in MM tumor cells overcomes resistance to hypoxia-mediated apoptosis in vitro and in vivo Gilberto Gastelum,Jeffry Kraut,Mysore S. Veena,Alisher Baibussinov,Chris Lamb,Kylee Lyons,Eric Y. Chang,Patrick Frost	2023	3
5	Can Targeting Hypoxia-Mediated Acidification of the Bone Marrow Microenvironment Kill Myeloma Tumor Cells? Gilberto Gastelum,Mysore S. Veena,Kylee Lyons,Chris Lamb,Nicole Jacobs,Alexandra Yamada,Alisher Baibussinov,Martin Sarafyan,Rebeka Shamis,Jeffry Kraut,Patrick Frost	2021	9
6	Dysregulation of hsa-miR-34a and hsa-miR-449a leads to overexpression of PACS-1 and loss of DNA damage response (DDR) in cervical cancer Mysore S. Veena,Santanu Raychaudhuri,Saroj K. Basak,Natarajan Venkatesan,Parameet Kumar,Roopa Biswas,Rita Chakrabarti,Jing Lü,Trent Su,Marcus Gallagher-Jones,Marco Morselli,Haiqing Fu,Matteo Pellegrini,Theodore C. Goldstein,Mirit I. Aladjem,Matthew B. Rettig,Sharon P. Wilczynski,Daniel Sanghoon Shin,Eri S. Srivatsan	2020	22
7	Restoration of the prolyl-hydroxylase domain protein-3 oxygen-sensing mechanism is responsible for regulation of HIF2α expression and induction of sensitivity of myeloma cells to hypoxia-mediated apoptosis Gilberto Gastelum,Aleksandra Poteshkina,Mysore S. Veena,Edgar Artiga,Geraldine Weckstein,Patrick Frost	2017	5
8	p16 Protein and Gigaxonin Are Associated with the Ubiquitination of NFκB in Cisplatin-induced Senescence of Cancer Cells Mysore S. Veena,Reason Wilken,Junying Zheng,Ankur A. Gholkar,Natarajan Venkatesan,Darshni Vira,Sameer Ahmed,Saroj K. Basak,Clifton L. Dalgard,Sandhiya Ravichandran,Raj K. Batra,Noriyuki Kasahara,David Elashoff,Michael C. Fishbein,Julian P. Whitelegge,Jorge Z. Torres,Marilene B. Wang,Eri S. Srivatsan	2014	24
9	Hyperactivated JNK Is a Therapeutic Target in pVHL-Deficient Renal Cell Carcinoma Jiabin An,Huiren Liu,Clara E. Magyar,Yanchuan Guo,Mysore S. Veena,Eri S. Srivatsan,Jiaoti Huang,Matthew B. Rettig	2013	45
10	Correction: The CD44^highTumorigenic Subsets in Lung Cancer Biospecimens Are Enriched for Low miR-34a Expression Saroj K. Basak,Mysore S. Veena,Scott Oh,Chi Lai,Sitaram Vangala,David Elashoff,Michael C. Fishbein,Sanjai Sharma,Nagesh Rao,Dinesh Rao,Ryan T. Phan,Eri S. Srivatsan,Raj K. Batra	2013	3
11	Cancer stem cells, microRNAs, and therapeutic strategies including natural products Darshni Vira,Saroj K. Basak,Mysore S. Veena,Marilene B. Wang,Raj K. Batra,Eri S. Srivatsan	2012	47
12	Curcumin Treatment Suppresses IKKβ Kinase Activity of Salivary Cells of Patients with Head and Neck Cancer: A Pilot Study Suejung G. Kim,Mysore S. Veena,Saroj K. Basak,Eugene Han,Tracey Tajima,David W. Gjertson,Joshua Starr,Ofer Eidelman,Harvey B. Pollard,Meera Srivastava,Eri S. Srivatsan,Marilene B. Wang	2011	96
13	Curcumin Enhances the Effect of Cisplatin in Suppression of Head and Neck Squamous Cell Carcinoma via Inhibition of IKKβ Protein of the NFκB Pathway Victor M. Duarte,Eugene Han,Mysore S. Veena,Amanda Salvado,Jeffrey D. Suh,Li‐Jung Liang,Kym F. Faull,Eri S. Srivatsan,Marilene B. Wang	2010	99
14	Suppression of Interleukin 6 and 8 Production in Head and Neck Cancer Cells With Curcumin via Inhibition of Iκβ Kinase Alen N. Cohen,Mysore S. Veena,Eri S. Srivatsan,Marilene B. Wang	2009	61
15	The Malignant Pleural Effusion as a Model to Investigate Intratumoral Heterogeneity in Lung Cancer Saroj K. Basak,Mysore S. Veena,Scott Oh,Ge Huang,Eri S. Srivatsan,Min Huang,Sherven Sharma,Raj K. Batra	2009	50
16	CAR mediates efficient tumor engraftment of mesenchymal type lung cancer cells Mysore S. Veena,Min Qin,Åsa Andersson,Sherven Sharma,Raj K. Batra	2009	15
17	Inactivation of the CYLD Deubiquitinase by HPV E6 Mediates Hypoxia-Induced NF-κB Activation Jiabin An,Deqiong Mo,Huiren Liu,Mysore S. Veena,Eri S. Srivatsan,Ramin Massoumi,Matthew B. Rettig	2008	86
18	Inactivation of the cystatin E/M tumor suppressor gene in cervical cancer Mysore S. Veena,Grant Lee,Daniel Keppler,Marc S. Mendonca,J. Leslie Redpath,Eric J. Stanbridge,Sharon P. Wilczynski,Eri S. Srivatsan	2008	29
19	Cisplatin-Induced Growth Arrest of Head and Neck Cancer Cells Correlates With Increased Expression of p16 and p53 Helena T. Yip,Rajesh Chopra,Rita Chakrabarti,Mysore S. Veena,Bharathi Ramamurthy,Eri S. Srivatsan,Marilene B. Wang	2006	30
20	A 700-kb physical and transcription map of the cervical cancer tumor suppressor gene locus on chromosome 11q13 Kayvan Zainabadi,Payam Benyamini,Rita Chakrabarti,Mysore S. Veena,Settara C. Chandrasekharappa,Richard A. Gatti,Eri S. Srivatsan	2005	21

About Mysore S. Veena

Mysore S. Veena is a scholar working on Molecular Medicine, Cancer Research and Oncology, having authored 28 papers that have together received 1.9k indexed citations. Recurring topics across this work include Curcumin's Biomedical Applications (6 papers), Retinoids in leukemia and cellular processes (6 papers), Cancer, Hypoxia, and Metabolism (5 papers), NF-κB Signaling Pathways (5 papers), RNA Interference and Gene Delivery (3 papers), MicroRNA in disease regulation (3 papers), Cancer Cells and Metastasis (3 papers) and RNA modifications and cancer (3 papers). The work is most often cited by research in Molecular Medicine (848 citations), Cancer Research (327 citations) and Pharmaceutical Science (98 citations). Mysore S. Veena has collaborated with scholars based in United States, Sweden and India. Frequent co-authors include Eri S. Srivatsan, Marilene B. Wang, Reason Wilken, Alen N. Cohen, Saroj K. Basak, Rita Chakrabarti, Kym F. Faull, Jeffrey D. Suh, Victor M. Duarte and Daniel Sanghoon Shin.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact